Kura Oncology Share Price - KURA

0.52 (1.76%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Monthly Subscription
for only
North American Extreme
Monthly Subscription
for only
USA Small Cap Basic
Monthly Subscription
for only
VAT not included
Stock Name Stock Symbol Market Stock Type
Kura Oncology Inc KURA NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
0.52 1.76% 30.05 23:00:10
Close Price Low Price High Price Open Price Previous Close
30.05 29.09 30.19 29.92 29.53
Bid Price Ask Price Spread News
30.05 34.90 4.85 - -
Trades Stocks Traded VWAP Financial Volume Average Volume 52 Week Range
8,203 1,103,359 US$ 29.84 US$ 32,925,028 747,182 6.34 - 30.19
Last Trade Type Quantity Price Currency
15:35:38 5 US$ 30.15 USD

Kura Oncology Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 1.69B 56.28M 47.13M US$ - US$ - -1.51 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- US$ - 0.00% -52.90k 0.70%

more financials information »

Kura Oncology News

Date Time Source News Article
9/15/202018:26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
9/15/202018:24Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
9/15/202018:23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
9/10/202017:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
9/10/202017:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
9/08/202006:30GlobeNewswire Inc.Kura Oncology to Participate in Two Upcoming Investor..
8/26/202017:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical KURA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week26.9830.1926.8728.63802,3803.0711.38%
1 Month21.6130.1920.6925.89789,7188.4439.06%
3 Months18.0630.1915.8821.88591,93311.9966.39%
6 Months7.2530.196.3417.54635,31422.80314.48%
1 Year16.4730.196.3416.37460,66713.5882.45%
3 Years13.5030.196.3416.62340,84116.55122.59%
5 Years8.7130.192.5014.78271,39021.34245.01%

Kura Oncology Description

Kura Oncology Inc is a clinical-stage biopharmaceutical company, engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progression of various cancers. The company has lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through the United States.
Your Recent History
Kura Oncol..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200919 10:53:51